Genmab | GEN - Aktywa

Cena Akcji
1,731.00
Dzienna Zmiana
-9.50 -0.55%
Miesięcznie
-7.48%
Rocznie
22.42%
Q1 Prognozy TE
1,638.96




Aktywa Zmiana Data
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Almirall EUR 2.34B 29.21M 2025-12
Amarin USD 659.81M 10.31M 2025-09
Amgen USD 90.59B 445M 2025-12
argenx SE USD 7.18B 973.07M 2025-06
AstraZeneca USD 114.07B 382M 2025-12
Bayer EUR 104.54B 331M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Demant DKK 39.07B 6.43B 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Fresenius Medical Care EUR 31B 115.33M 2025-12
Galapagos EUR 3.41B 105.39M 2025-12
Genmab DKK 6.46B 122M 2025-06
GlaxoSmithKline GBP 61.12B 221M 2025-12
GN Store Nord DKK 29.23B 170M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
UCB EUR 17.35B 1.72B 2024-12